Jane Street Group, LLC Solid Biosciences Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 16, 2021	SELL	$2.38 - $3.77 $75,208 - $119,132	-31,600 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $402,048 - $634,752	-115,200 Reduced 78.47%	31,600 $116,000
Q1 2021 May 18, 2021	BUY	$5.37 - $10.72 $590,700 - $1.18 Million	110,000 Added 298.91%	146,800 $812,000
Q4 2020 Feb 17, 2021	BUY	$3.08 - $7.79 $113,344 - $286,672	36,800 New	36,800 $279,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.